Facilitated Immunoglobulin Administration Registry and Outcomes Study (FIGARO)

CompletedOBSERVATIONAL

Enrollment

156

Participants

Timeline

Start Date

December 22, 2016

Primary Completion Date

November 30, 2021

Study Completion Date

November 30, 2021

Conditions

Primary ImmunodeficiencySecondary Immune Deficiency

Interventions

BIOLOGICAL

HyQvia

Trial Locations (4)

University Hospital, Paris

Charité, Berlin

Hospital for Children and Adolescents, St. Georg Hospital, Academic Teaching Hospital, Leipzig

La Sapienza University, Roma

All Listed Sponsors

lead

GWT-TUD GmbH

OTHER

NCT03054181 - Facilitated Immunoglobulin Administration Registry and Outcomes Study (FIGARO) | Biotech Hunter | Biotech Hunter